HOME >> BIOLOGY >> NEWS
Promising protein may prevent eye damage in premature babies

the protein IGFBP-3 as a promising therapeutic agent after analyzing data from mouse and human studies.

This discovery has a big future in helping premature babies, said Alexander V. Ljubimov, Ph.D., a professor of medicine at UCLA and director of Ophthalmology Research Laboratories at Cedars-Sinai Medical Center. The idea is to administer this already clinically available protein to premature babies to stabilize the existing vessels in the retina, prevent their loss and block the compensatory growth of new, aberrant vessels. Finding the right dose may enable babies to cope with the first phases of their life without becoming blind.

Retinopathy of prematurity affects infants weighing less than 2.75 pounds who are born within the first 31 weeks of pregnancy, according to the National Eye Institute. More than 1,000 require medical treatment and about 500 become legally blind.

Treatments based on IGFBP-3 could advance relatively quickly because it is a natural protein and presumably safe, Ljubimov said.

The discovery has added credibility because independent research groups took different approaches to show essentially the same thing, said Ljubimov, who was not involved in the research. There is independent confirmation from totally different research teams within the same journal.

At UF, researchers infused IGFBP-3 into one eye of each of nine mice before placing the animals into a high-oxygen chamber for five days. When scientists compared vascular growth within the retinas, they found blood vessels were closer to normal in eyes treated with IGFBP-3.

When UF scientists repeated the experiment in 18 mice treated with bone marrow stem cells expressing IGFBP-3, they found the treated eyes developed normally.

In addition to studies in mice, Harvard research collaborators in Sweden examined infants with retinopathy of prematurity in a prospective clinical study and found that the IGFBP-3 levels were low
'"/>

Contact: John Pastor
jdpastor@ufl.edu
352-273-5815
University of Florida
18-Jun-2007


Page: 1 2 3

Related biology news :

1. Tailored treatments: Promising designer drug provides new insight into cancer biology
2. Promising antiobesity drug fails to produce clinically meaningful weight loss
3. Promising preclinical results with live attenuated H5N1 vaccines
4. Promising new research on hereditary diseases
5. Promising cell protein may play role in infection and dry eye
6. Promising anti-TB compound finally can be synthesized with ease
7. Promising results in the battle against incurable ALS muscle disease
8. Promising new preventative treatment option for population of men at high risk of prostate cancer
9. Penn researchers discover how key protein stops inflammation
10. UCF research links proteins, stem cells and potential Alzheimers treatment
11. Teamwork between 2 key proteins necessary for normal development and regulation of red blood cells

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2020)... ... June 23, 2020 , ... ... monoclonal antibody development services, today announced that the company has received ISO9001:2015 ... the pharmaceutical, diagnostics, and research industries. The decision to pursue ISO9001 accreditation ...
(Date:6/23/2020)... ... June 22, 2020 , ... The field of quantitation ... binding assays (LBA) have dominated this area. However, the use of mass spectrometry in ... This now necessitates the question “How do you choose which approach to use (LBA ...
(Date:6/23/2020)... ... ... In its June 22 online post, business and technology news platform Superb ... founder and director of stem cell biotechnology company Asymmetrex . Superb Crew decided ... July 5 it would begin offering free tissue stem cell counting at ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... 09, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology ... R. Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. Dr. Nissenson will ... SBI-101. Dr. Nissenson serves as an Emeritus Professor of Medicine at the ...
(Date:7/1/2020)... ... June 29, 2020 , ... ... growth of 40% in 2020, despite many obstacles created as a result of ... increase revenue for its partnered medical practices and medical manufacturers by expanding access ...
(Date:6/28/2020)... , ... June 25, 2020 , ... The Indoor Lab, ... of Safe Space™ for businesses of all types to ensure cleanliness, distancing and occupancy ... , A Safe Space™ enabled business will provide a health performance index system ...
(Date:6/28/2020)... (PRWEB) , ... June 26, 2020 , ... ... association representing security solutions providers, today announced its strong opposition to the recently ... bill would impose a blanket ban on most federal use of nearly all ...
Breaking Biology Technology:
Cached News: